Ocular implant with stiffness qualities, methods of implantation and system
First Claim
1. An ocular implant system for implantation into an eye, comprising:
- an ocular implant having;
(a) an elongate member comprising a wall material having sufficient stiffness such that, when the elongate member is implanted in a deployed location in the eye, the elongate member is able to transition from a curved shape to a straight shape so as to deform sub-scleral eye tissue adjacent the elongate member so as to form a tented volume beneath the sclera; and
(b) an internal lumen within the elongate member configured to form a flow pathway;
(c) at least one inflow port communicating with the internal lumen; and
(d) at least one outflow port communicating with the internal lumen;
wherein, when the elongate member is positioned in the deployed location, the at least one inflow port communicates with the anterior chamber and the at least one outflow port is positioned to drain aqueous humor from the anterior chamber toward the suprachoroidal space.
3 Assignments
0 Petitions
Accused Products
Abstract
Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.
-
Citations
30 Claims
-
1. An ocular implant system for implantation into an eye, comprising:
-
an ocular implant having; (a) an elongate member comprising a wall material having sufficient stiffness such that, when the elongate member is implanted in a deployed location in the eye, the elongate member is able to transition from a curved shape to a straight shape so as to deform sub-scleral eye tissue adjacent the elongate member so as to form a tented volume beneath the sclera; and (b) an internal lumen within the elongate member configured to form a flow pathway; (c) at least one inflow port communicating with the internal lumen; and (d) at least one outflow port communicating with the internal lumen; wherein, when the elongate member is positioned in the deployed location, the at least one inflow port communicates with the anterior chamber and the at least one outflow port is positioned to drain aqueous humor from the anterior chamber toward the suprachoroidal space. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. An ocular implant system for implantation into an eye, comprising:
-
an ocular implant having; (a) an elongate member having sufficient stiffness such that, when the elongate member is implanted in a deployed location in the eye, the elongate member is able to transition from a curved shape to a straight shape so as to deform sub-scleral eye tissue adjacent the elongate member so as to form a tented volume beneath the sclera; and (b) an internal lumen within the elongate member configured to form a flow pathway; (c) at least one inflow port communicating with the internal lumen; and (d) at least one outflow port communicating with the internal lumen; wherein, when the elongate member is positioned in the deployed location, the at least one inflow port communicates with the anterior chamber and the at least one outflow port is positioned to drain aqueous humor from the anterior chamber into the tented volume. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification